Bipolar Disorder



Occupational Stress and Bipolar Disorder


Condition:   Bipolar Disorder
Intervention:   Other: Date collection
Sponsor:   University Hospital, Montpellier
Recruiting - verified May 2017


Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies


Condition:   Bipolar Disorder
Interventions:   Drug: Lithium Carbonate;   Drug: Lamotrigine;   Drug: Valproic Acid;   Drug: Oxcarbazepine;   Drug: Carbamazepine;   Drug: Ziprasidone;   Drug: Risperidone;   Drug: Quetiapine;   Drug: Olanzapine;   Drug: Aripiprazole;   Drug: Fluoxetine / Olanzapine
Sponsors:   University of New Mexico;   Patient-Centered Outcomes Research Institute;   Montana State University;   National Alliance on Mental Illness;   CGStat LLC;   Risk Benefit Statistics LLC
Not yet recruiting - verified September 2016


fMRI of Flight of Ideas in Bipolar Disorder


Condition:   Bipolar Disorder
Intervention:   Other: Functional Magnetic Resonance Imaging
Sponsor:   CHU de Reims
Recruiting - verified May 2016


Emotion Recognition Modification for Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Other: emotion recognition modification - sad>happy;   Other: emotion recognition modification - sad>happy control;   Other: emotion recognition modification - angry>happy;   Other: emotion recognition modification - angry>happy control
Sponsor:   Yeshiva University
Recruiting - verified July 2016


Internet Psychotherapy for Bipolar Disorder in Primary Care


Condition:   Bipolar Disorder
Interventions:   Behavioral: i-IPSRT;   Other: Written Psychoeducation
Sponsors:   University of Pittsburgh;   Northwestern University
Not yet recruiting - verified August 2016


A Mobile Behavioral Monitoring Intervention for Bipolar Disorder


Condition:   Bipolar Disorder
Intervention:   Behavioral: LiveWell System
Sponsors:   Northwestern University;   National Institute of Mental Health (NIMH)
Completed - verified April 2017


Targeting Cognition in Bipolar Disorder With Pramipexole


Condition:   Bipolar Disorder
Interventions:   Drug: Pramipexole;   Drug: Placebo
Sponsors:   Brigham and Women's Hospital;   The Zucker Hillside Hospital;   Northwell Health;   National Institute of Mental Health (NIMH);   Icahn School of Medicine at Mount Sinai
Recruiting - verified April 2017


Dietary Intervention for Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Other: Experimental Diet;   Other: Comparator Diet
Sponsors:   Milton S. Hershey Medical Center;   Stanley Medical Research Institute
Recruiting - verified March 2017


Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II Trial


Condition:   Bipolar Disorder
Interventions:   Device: The MONARCA II system;   Device: Non-MONARCA II system
Sponsors:   Psychiatric Centre Rigshospitalet;   University of Copenhagen;   IT University of Copenhagen
Recruiting - verified January 2017


Internet-Based Interventions for Bipolar Disorder (MoodSwings 2)


Condition:   Bipolar Disorder
Interventions:   Behavioral: Moderated discussion board;   Behavioral: Psychoeducation;   Behavioral: Interactive Psychosocial Tools
Sponsors:   University of Melbourne;   VA Palo Alto Health Care System
Active, not recruiting - verified October 2016


Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil


Condition:   Bipolar Disorder
Interventions:   Drug: Modafinil;   Drug: Placebo
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Institute of Mental Health (NIMH)
Recruiting - verified December 2016


A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Other: CR + DCS (D-cycloserine);   Other: CR + placebo
Sponsor:   University of Arizona
Completed - verified April 2017


N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Drug: Asprin;   Dietary Supplement: N-acetyl-cysteine (NAC);   Drug: Asprin and NAC;   Drug: Sugar Pill
Sponsors:   The University of Texas Health Science Center, Houston;   Stanley Medical Research Institute
Completed - verified April 2017


Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Other: Nutrition, Exercise, and Wellness (NEW) psychotherapy;   Drug: Typically consists of at least one FDA-approved mood stabilizer
Sponsor:   Massachusetts General Hospital
Active, not recruiting - verified September 2016


Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Drug: Ketamine hydrochloride injection;   Drug: Flat tonic water (e.g., Canada Dry Tonic Water)
Sponsor:   Juvenile Bipolar Research Foundation
Terminated - verified March 2017


Decision-Making in Bipolar Disorder


Condition:   Bipolar Disorder
Intervention:   Drug: Lithium, valproate, lamotrigine
Sponsor:   Emory University
Completed - verified September 2016


Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Drug: quetiapine SR;   Drug: quetiapine sr placebo
Sponsors:   The University of Texas Health Science Center at San Antonio;   AstraZeneca
Completed - verified March 2017


Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child


Condition:   Bipolar Disorder
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Completed - verified June 7, 2013


Memantine and Cognitive Dysfunction in Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Drug: Memantine;   Drug: Placebo
Sponsors:   Massachusetts General Hospital;   Forest Laboratories
Completed - verified March 2017


Divalproex vs. Lamotrigine for Bipolar Disorder


Condition:   Bipolar Disorder
Intervention:  
Sponsor:   Tuscaloosa Research & Education Advancement Corporation
Terminated - verified April 2017


An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder


Condition:   Bipolar Disorder
Intervention:   Drug: lamotrigine
Sponsor:   GlaxoSmithKline
Completed - verified February 2017


Depression And Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Drug: Placebo;   Drug: lamotrigine
Sponsor:   GlaxoSmithKline
Completed - verified September 2016


Effects of Psycho-education of Patients With Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Behavioral: individual education;   Behavioral: Group education
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Norwegian Council for Mental Health;   Norwegian Foundation for Health and Rehabilitation
Completed - verified September 2015


The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.


Condition:   Bipolar Disorder
Intervention:   Drug: Oxcarbazepine
Sponsor:   Novartis
Completed - verified February 2017


Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder


Condition:   Bipolar Disorder
Interventions:   Drug: Licarbazepine;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified March 2017

Refine Your Search Advanced Search